IL158733A0 - Granular preparations of gaboxadol - Google Patents

Granular preparations of gaboxadol

Info

Publication number: IL158733A0
Authority: IL; Israel
Prior art keywords: gaboxadol; granular preparations; granular; preparations
Prior art date: 2001-05-21

Application number

IL15873302A

Other languages

English (en)

Original Assignee

Lundbeck & Co As H

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-05-21

Filing date

2002-05-17

Publication date

2004-05-12

2002-05-17 Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H

2004-05-12 Publication of IL158733A0 publication Critical patent/IL158733A0/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Inorganic Chemistry (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

IL15873302A 2001-05-21 2002-05-17 Granular preparations of gaboxadol IL158733A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA200100817		2001-05-21
PCT/DK2002/000332 WO2002094225A1 (en)	2001-05-21	2002-05-17	Granular preparations of gaboxadol

Publications (1)

Publication Number	Publication Date
IL158733A0 true IL158733A0 (en)	2004-05-12

Family

ID=8160520

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL15873302A IL158733A0 (en)	2001-05-21	2002-05-17	Granular preparations of gaboxadol

Country Status (26)

Country	Link
US (1)	US20040157876A1 (is)
EP (1)	EP1389091A1 (is)
JP (1)	JP2004530695A (is)
KR (1)	KR20030097890A (is)
CN (1)	CN1511026A (is)
AR (1)	AR033896A1 (is)
AU (1)	AU2002338855B2 (is)
BG (1)	BG108441A (is)
BR (1)	BR0209834A (is)
CA (1)	CA2447603A1 (is)
CZ (1)	CZ20033269A3 (is)
EA (2)	EA009731B1 (is)
HR (1)	HRP20030950A2 (is)
HU (1)	HUP0400051A2 (is)
IL (1)	IL158733A0 (is)
IS (1)	IS7020A (is)
ME (1)	MEP6308A (is)
MX (1)	MXPA03010596A (is)
NO (1)	NO20035146D0 (is)
NZ (1)	NZ547636A (is)
PL (1)	PL366541A1 (is)
SK (1)	SK15542003A3 (is)
UA (1)	UA80092C2 (is)
WO (1)	WO2002094225A1 (is)
YU (1)	YU92103A (is)
ZA (1)	ZA200308594B (is)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1220658A1 (en) *	1999-09-28	2002-07-10	H. Lundbeck A/S	Melt granulated composition and modified release dosage form prepared from said composition
AU2004248890A1 (en)	2003-06-25	2004-12-29	H. Lundbeck A/S	Gaboxadol for treating depression and other affective disorders
TW200528098A (en) *	2003-12-18	2005-09-01	Lundbeck & Co As H	Treatment of insomnia in human patients
GB0402118D0 (en)	2004-01-30	2004-03-03	Merck Sharp & Dohme	Polymorphic forms of a GABAA agonist
WO2006083682A2 (en)	2005-01-28	2006-08-10	H.Lundbeck A/S	Polymorphic forms of a gabaa agonist
US20080262029A1 (en) *	2005-04-29	2008-10-23	H. Lundbeck A/S	Acid and Base Salt Forms of Gaboxadol
WO2009148891A1 (en) *	2008-05-30	2009-12-10	Psychogenics, Inc.	Treatment for neurological and mental disorders
EP2334299A1 (en) *	2008-09-01	2011-06-22	H. Lundbeck A/S	Pharmaceutical composition comprising gaboxadol and an inhibitor of patl or oat
CA2859174C (en) *	2011-12-12	2019-03-05	Orbis Biosciences, Inc.	Sustained release particle formulations
IL256912B2 (en)	2015-07-17	2024-01-01	Ovid Therapeutics Inc	Methods of treating developmental disorders with gaboxadol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4315934A (en) *	1979-09-24	1982-02-16	Sandoz Ltd.	Organic compounds
DE19525598C2 (de) *	1995-07-13	1997-09-25	Max Planck Gesellschaft	Schlafmittel
US6649186B1 (en) *	1996-09-20	2003-11-18	Ethypharm	Effervescent granules and methods for their preparation
EP1220658A1 (en) *	1999-09-28	2002-07-10	H. Lundbeck A/S	Melt granulated composition and modified release dosage form prepared from said composition
US6375982B1 (en) *	2000-07-05	2002-04-23	Capricorn Pharma, Inc.	Rapid-melt semi-solid compositions, methods of making same and method of using same

2002
- 2002-05-17 UA UA20031110120A patent/UA80092C2/uk unknown
- 2002-05-17 MX MXPA03010596A patent/MXPA03010596A/es not_active Application Discontinuation
- 2002-05-17 AR ARP020101839A patent/AR033896A1/es unknown
- 2002-05-17 EA EA200301282A patent/EA009731B1/ru not_active IP Right Cessation
- 2002-05-17 CA CA002447603A patent/CA2447603A1/en not_active Abandoned
- 2002-05-17 KR KR10-2003-7015136A patent/KR20030097890A/ko not_active Ceased
- 2002-05-17 JP JP2002590944A patent/JP2004530695A/ja active Pending
- 2002-05-17 ME MEP-63/08A patent/MEP6308A/xx unknown
- 2002-05-17 YU YU92103A patent/YU92103A/sh unknown
- 2002-05-17 EP EP02742834A patent/EP1389091A1/en not_active Ceased
- 2002-05-17 EA EA200700703A patent/EA200700703A1/ru unknown
- 2002-05-17 CN CNA028104587A patent/CN1511026A/zh active Pending
- 2002-05-17 SK SK1554-2003A patent/SK15542003A3/sk not_active Application Discontinuation
- 2002-05-17 HU HU0400051A patent/HUP0400051A2/hu unknown
- 2002-05-17 CZ CZ20033269A patent/CZ20033269A3/cs unknown
- 2002-05-17 NZ NZ547636A patent/NZ547636A/en unknown
- 2002-05-17 PL PL02366541A patent/PL366541A1/xx not_active Application Discontinuation
- 2002-05-17 HR HR20030950A patent/HRP20030950A2/hr not_active Application Discontinuation
- 2002-05-17 US US10/478,983 patent/US20040157876A1/en not_active Abandoned
- 2002-05-17 WO PCT/DK2002/000332 patent/WO2002094225A1/en not_active Ceased
- 2002-05-17 AU AU2002338855A patent/AU2002338855B2/en not_active Ceased
- 2002-05-17 IL IL15873302A patent/IL158733A0/xx unknown
- 2002-05-17 BR BR0209834-2A patent/BR0209834A/pt not_active IP Right Cessation
2003
- 2003-11-04 ZA ZA200308594A patent/ZA200308594B/en unknown
- 2003-11-10 IS IS7020A patent/IS7020A/is unknown
- 2003-11-19 NO NO20035146A patent/NO20035146D0/no not_active Application Discontinuation
- 2003-12-12 BG BG108441A patent/BG108441A/xx unknown

Also Published As

Publication number	Publication date
UA80092C2 (en)	2007-08-27
EA009731B1 (ru)	2008-02-28
EP1389091A1 (en)	2004-02-18
CA2447603A1 (en)	2002-11-28
BR0209834A (pt)	2004-06-15
HUP0400051A2 (hu)	2004-04-28
SK15542003A3 (sk)	2004-05-04
KR20030097890A (ko)	2003-12-31
WO2002094225A1 (en)	2002-11-28
NO20035146L (no)	2003-11-19
US20040157876A1 (en)	2004-08-12
YU92103A (sh)	2006-05-25
AR033896A1 (es)	2004-01-07
JP2004530695A (ja)	2004-10-07
NO20035146D0 (no)	2003-11-19
CN1511026A (zh)	2004-07-07
AU2002338855B2 (en)	2007-08-16
BG108441A (en)	2005-02-28
HRP20030950A2 (en)	2005-08-31
CZ20033269A3 (en)	2004-03-17
IS7020A (is)	2003-11-10
ZA200308594B (en)	2004-11-04
PL366541A1 (en)	2005-02-07
MEP6308A (xx)	2010-02-10
MXPA03010596A (es)	2004-03-09
NZ547636A (en)	2008-03-28
EA200700703A1 (ru)	2007-08-31
EA200301282A1 (ru)	2004-04-29

Publication	Publication Date	Title
PT1438306E (pt)	2014-06-03	Derivados de uk-20
EP1578910A4 (en)	2008-06-04	NITRILASES
GB2376583B (en)	2005-01-05	Time alignment of signals
IL157426A0 (en)	2004-03-28	Peg-conjugates of hgf-nk4
EP1434772A4 (en)	2005-05-04	CONNECTIONS AND METHODS
IL158733A0 (en)	2004-05-12	Granular preparations of gaboxadol
GB0126889D0 (en)	2002-01-02	Compounds and their uses
AU2002359694A8 (en)	2003-06-30	Compounds and methods
HUP0500734A3 (en)	2005-12-28	Use of 2-alkoxyphenyl-substituted imidazotriazinones
GB0125708D0 (en)	2001-12-19	Novel compounds and processes
IL161178A0 (en)	2004-08-31	MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
AU2002358719A1 (en)	2003-07-15	Agaricoglycerides and analogs
EP1379240A4 (en)	2009-04-08	CONNECTIONS AND METHODS
AU2003298725A8 (en)	2004-06-23	Preparation of metallotexaphyrins
GB0100151D0 (en)	2001-02-14	Methods of sputtering
TW493722U (en)	2002-07-01	Improved structure of lampwick
IL157243A0 (en)	2004-02-19	Preparation of n-methylparoxetine and related intermediate compounds
AU2002359898A1 (en)	2003-07-24	Preparation of alpha-diimines
AU150489S (en)	2003-01-31	Set of chamfered logs
HU0104370D0 (en)	2001-12-28	Honeyed schnaps of oerseg
TW573751U (en)	2004-01-21	Structure capable of preventing jaming
IL165356A0 (en)	2006-01-15	Preparation of 4-haloalkylkylnicotinamides
AU2002300773A1 (en)	2003-06-12	Preparation of Dialkylpyridylboranes
GB0105097D0 (en)	2001-04-18	Treatment of technetium
GB0104615D0 (en)	2001-04-11	Treatment of technetium